Kimberlee A Musser
Biographic Data
| ID | 9993936 |
|---|---|
| NAME | Kimberlee A Musser |
| GIVEN NAMES | Kimberlee A |
| FAMILY NAME | Musser |
| SIGNATURE | MUSSER K A |
| AFFILIATIONS | New York State Department of Health |
| ORCID | 0000-0003-1922-5405 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State
Bacterial meningitis and septicemia caused by Neisseria meningitidis is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of N. meningitidis serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. N. meningitidis serogroup Y is of particular concern because these strains demons…
Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing
Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…
No prominent works on this page.
Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing
Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…
Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State
Bacterial meningitis and septicemia caused by Neisseria meningitidis is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of N. meningitidis serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. N. meningitidis serogroup Y is of particular concern because these strains demons…
Amplicon (1 work) · Antibiotic resistance (1 work) · Antibiotic Resistance in Bacteria (1 work) · Bacterial Infections and Vaccines (1 work) · Biology (1 work) · Ciprofloxacin (1 work) · Drug resistance (1 work) · Gene (1 work) · Genetics (1 work) · Infective Endocarditis Diagnosis and Management (1 work)